Eikon Therapeutics logo

Eikon Therapeutics

ID: 7644252

Eikon Therapeutics is developing a new method of drug discovery based on tracking and measuring the movement of individual proteins in live cells.

2

Funding Rounds

$666.0m

Money raised

Overview

Eikon Therapeutics is developing a new method of drug discovery based on tracking and measuring the movement of individual proteins in live cells.

Unlock Complete Company Intelligence

Access comprehensive data and insights available only to Seedtable members

Financial Details

  • • Complete funding history and valuations
  • • Revenue estimates and financial metrics
  • • Investment round details and terms

People & Contacts

  • • Complete leadership team profiles
  • • Contact information and email addresses
  • • Board members and advisors

Market Intelligence

  • • Competitive landscape analysis
  • • Market position and growth metrics
  • • Industry benchmarking data

Premium Tools

  • • Export data and generate reports
  • • Save companies to custom watchlists
  • • API access for data integration

Join 10,000+ Professionals

Trusted by investors, founders, and analysts worldwide

Access detailed insights on 71,000+ companies worldwide

Funding

Funding series

Funding Series Analysis

The company Eikon Therapeutics has raised a total of $666m in funding over 2 rounds.

Key Insights:

  • Eikon Therapeutics Series B round, January 2022: $518m
  • Eikon Therapeutics Series A round, May 2021: $148m

Industries

Eikon Therapeutics is active in the following industries: